Armata Pharmaceuticals Inc (ARMP)
AMEX
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -97.714 | -87.533 | -105.19 | -104.339 | -68.284 | -42.376 | -44.585 | -71.108 |
Return on Equity (%) | -216.393 | -147.107 | -149.46 | -168.891 | -132.622 | -104.646 | -120.1 | -3439.352 |
Return on Invested Capital (%) | -123.78 | -116.19 | -130.967 | -151.412 | -141.424 | -121.504 | -147.392 | -117.259 |
Operating Margin (%) | -7459.231 | -12295.652 | N/A | N/A | -2618.834 | -516.115 | -670.243 | -1466.527 |
Net Profit Margin (%) | -9336.923 | -11163.478 | N/A | N/A | -2695.14 | -517.546 | -670.243 | -1524.509 |
Book Value Per Share | -0.016 | 0.047 | 0.066 | 0.014 | 0.074 | 0.15 | 0.258 | -0.528 |
Earnings Per Share | -0.362 | -0.214 | -0.146 | -0.322 | -0.32 | -0.298 | -0.426 | -0.796 |
Cash Per Share | 0.085 | 0.085 | 0.098 | 0.1 | 0.139 | 0.132 | 0.171 | 0.156 |
Working Capital Per Share | 0.041 | 0.057 | 0.07 | 0.029 | 0.06 | 0.131 | 0.025 | 0.031 |
Operating Profit Per Share | 0.004 | 0.002 | N/A | N/A | 0.012 | 0.058 | 0.064 | 0.052 |
EBIT Per Share | -0.289 | -0.235 | -0.15 | -0.322 | -0.32 | -0.298 | -0.426 | -0.796 |
EBITDA Per Share | -0.289 | -0.235 | -0.15 | -0.322 | -0.32 | -0.298 | -0.426 | -0.796 |
Free Cash Flow Per Share | -0.363 | -0.219 | -0.15 | -0.341 | -0.324 | -0.296 | -0.41 | -0.713 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1820.352 | N/A | N/A | N/A | -2401.76 | N/A | N/A |
Net Profit Margin (%) | N/A | -1820.352 | N/A | N/A | N/A | -2590.166 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 73,81M |
Ratio cours/bénéfice | 0 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0 |
Rendement de dividende | - |
Actions en circulation | 36,18M |
Volume moyen (1 semaine) | 5,42k |
Volume moyen (1 mois) | 13,72k |
Variation sur 52 semaines | -44,32% |
Plus haut sur 52 semaines | 4,48 |
Plus bas sur 52 semaines | 1,80 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales